All previous studies, together with our results, open the possibility of a further series of experiments needed to corroborate whether the TRPC1–TRPC5 interaction could be used as a mechanism to decelerate inner retinal degeneration, thus providing more treatment options for RP patients. This evidence concerns the gene TRPC5 and retinitis pigmentosa 1.